Back
Biomarin Pharmaceutical Stock Price Chart
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Buy
52
BMRN
Biomarin Pharmaceutical
Last Price:
82.47
Seasonality Move:
6.56%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.34 | Sell |
| 20-day SMA: | 87.5 | Sell |
| 50-day SMA: | 86.97 | Sell |
| 200-day SMA: | 88.97 | Sell |
| 8-day EMA: | 83.87 | Sell |
| 20-day EMA: | 85.86 | Sell |
| 50-day EMA: | 87.22 | Sell |
| 200-day EMA: | 89.34 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.48 | Sell |
| Relative Strength Index (14 RSI): | 39.63 | Sell |
| Chaikin Money Flow: | -1474758 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (83.72 - 91.04) | Sell |
| Bollinger Bands (100): | (85.42 - 94.44) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 82.44 while BMRN 8-day simple moving average is 83.34, which is a Sell signal.
- The stock price of BMRN is 82.44 while Biomarin Pharmaceutical 20-day SMA is 87.50, which makes it a Sell.
- Biomarin Pharmaceutical 50-day simple moving average is 86.97 while BMRN share price is 82.44, making it a Sell technically.
- BMRN stock price is 82.44 and Biomarin Pharmaceutical 200-day simple moving average is 88.97, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
52
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Buy
The current Biomarin Pharmaceutical [BMRN] share price is $82.44. The Score for BMRN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
15.65B
Price in USD:
82.44
Share Volume:
1.63M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.56
52-Week Low:
76.02
Buy
52
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?
The Biomarin Pharmaceutical stock price is 82.44 USD today. -
Will BMRN stock go up or go down?
Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Biomarin Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 82.44 while BMRN 8-day exponential moving average is 83.87, which is a Sell signal.
- The stock price of BMRN is 82.44 while Biomarin Pharmaceutical 20-day EMA is 85.86, which makes it a Sell.
- Biomarin Pharmaceutical 50-day exponential moving average is 87.22 while BMRN share price is 82.44, making it a Sell technically.
- BMRN stock price is 82.44 and Biomarin Pharmaceutical 200-day simple moving average is 89.34, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.09 per share, an increase this year of $0.83 per share, and an increase next year of $0.89 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
- BMRN Moving Average Covergence Divergence (MACD) indicator is -1.48, suggesting Biomarin Pharmaceutical is a Sell
- Biomarin Pharmaceutical Relative Strength Index (RSI) is 39.63, which suggest Biomarin Pharmaceutical is oversold
- The Bollinger Bands (25) for Biomarin Pharmaceutical is (83.72 - 91.04), which suggest Biomarin Pharmaceutical is a Sell
- The Bollinger Bands (100) for Biomarin Pharmaceutical is (85.42 - 94.44), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.